Results of multiple linear regression models with control for confounding variables. Values are β coefficients (95% confidence intervals) and p values. AD, Alzheimer’s disease; MCI, mild cognitive impairment; NHS, normal healthy subjects; SMC, subjective memory complaint. (PDF 75 kb
Table S1. Mouse microglial transcriptomic modules identified by Weighted Correlation Network Analysi...
Additional file 1: Supplemental Table 1. List of biomarkers measured with Olink Proseek® Multiplex I...
Compiled values for all biomarkers measured in the plasma of aMCI vs NC subjects. Data for the measu...
Results of multiple linear regression models without control for confounding variables. Values are β...
Table S1. Characteristics of the primary antibodies, immunohistochemistry conditions and expression ...
Demographic and biomarker information for cognitive normal subjects and MCI patients with CSF t-Tau/...
Table S2. Cut-offs used for defining pre-clinical Alzheimer’s disease according biomarkers positivit...
Figure S8. (a) Correlation plot graphing T resp. proliferation suppression and myeloid IL-6 transcri...
Table S1. Demographic, clinical and genetic data of the MCI subgroups based on a CSF biomarker profi...
Table S1. Literature overview CSF immune markers in AD clinical groups. (DOCX 72 kb
YKL-40 is correlated with t-tau and p-tau in non-AD subjects. CSF levels of YKL-40 in the non-AD gro...
Table S1. Sample set description. Table S2. MR replication in release 2 of the UK Biobank data. Tabl...
Figure S1. Receiver operating characteristics (ROC) curves for (A) distinguishing between AD-dementi...
Figure S2. Between-group comparisons of microglial- and astroglial activation with inflammation base...
Table S1. Overview of median blood cell counts and blood cell-based ratios measured per Rotterdam St...
Table S1. Mouse microglial transcriptomic modules identified by Weighted Correlation Network Analysi...
Additional file 1: Supplemental Table 1. List of biomarkers measured with Olink Proseek® Multiplex I...
Compiled values for all biomarkers measured in the plasma of aMCI vs NC subjects. Data for the measu...
Results of multiple linear regression models without control for confounding variables. Values are β...
Table S1. Characteristics of the primary antibodies, immunohistochemistry conditions and expression ...
Demographic and biomarker information for cognitive normal subjects and MCI patients with CSF t-Tau/...
Table S2. Cut-offs used for defining pre-clinical Alzheimer’s disease according biomarkers positivit...
Figure S8. (a) Correlation plot graphing T resp. proliferation suppression and myeloid IL-6 transcri...
Table S1. Demographic, clinical and genetic data of the MCI subgroups based on a CSF biomarker profi...
Table S1. Literature overview CSF immune markers in AD clinical groups. (DOCX 72 kb
YKL-40 is correlated with t-tau and p-tau in non-AD subjects. CSF levels of YKL-40 in the non-AD gro...
Table S1. Sample set description. Table S2. MR replication in release 2 of the UK Biobank data. Tabl...
Figure S1. Receiver operating characteristics (ROC) curves for (A) distinguishing between AD-dementi...
Figure S2. Between-group comparisons of microglial- and astroglial activation with inflammation base...
Table S1. Overview of median blood cell counts and blood cell-based ratios measured per Rotterdam St...
Table S1. Mouse microglial transcriptomic modules identified by Weighted Correlation Network Analysi...
Additional file 1: Supplemental Table 1. List of biomarkers measured with Olink Proseek® Multiplex I...
Compiled values for all biomarkers measured in the plasma of aMCI vs NC subjects. Data for the measu...